SUPERNUS PHARMACEUTICALS INC (SUPN) Forecast, Price Target & Analyst Ratings

NASDAQ:SUPN • US8684591089

Current stock price

49.345 USD
-1.45 (-2.86%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SUPERNUS PHARMACEUTICALS INC (SUPN).

Forecast Snapshot

Consensus Price Target

Price Target
$62.56
+ 26.78% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
$0.50
Revenue Estimate
196.82M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
83.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$62.56
Upside
+ 26.78%
From current price of $49.35 to mean target of $62.56, Based on 12 analyst forecasts
Low
$55.55
Median
$62.73
High
$68.25

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

12 Wall Street analysts provided a forecast for the next 12 months for SUPN. The average price target is 62.56 USD. This implies a price increase of 26.78% is expected in the next year compared to the current price of 49.345.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

SUPN Current Analyst RatingSUPN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

SUPN Historical Analyst RatingsSUPN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
83.33%
SUPN was analyzed by 12 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about SUPN.
In the previous month the buy percentage consensus was at a similar level.
SUPN was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-12-19StifelMaintains Hold -> Hold
2025-10-29B of A SecuritiesInitiate Buy
2025-10-23TD CowenMaintains Buy -> Buy
2025-10-09Piper SandlerUpgrade Neutral -> Overweight
2025-09-30Cantor FitzgeraldMaintains Overweight -> Overweight
2025-08-29Piper SandlerMaintains Neutral -> Neutral
2025-08-06Cantor FitzgeraldMaintains Overweight -> Overweight
2025-02-26Cantor FitzgeraldReiterate Neutral -> Neutral
2025-02-19Cantor FitzgeraldDowngrade Overweight -> Neutral
2024-09-11Piper SandlerDowngrade Overweight -> Neutral
2024-02-28Piper SandlerMaintains Overweight -> Overweight
2023-11-09Piper SandlerMaintains Overweight -> Overweight
2023-10-25Piper SandlerMaintains Overweight -> Overweight
2023-05-10Piper SandlerMaintains Overweight -> Overweight
2023-01-23Piper SandlerMaintains Overweight
2022-08-31Piper SandlerMaintains Overweight
2021-04-13JefferiesUpgrade Hold -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
$0.50
Revenue Estimate
196.82M
Revenue Q2Q
31.37%
EPS Q2Q
14.75%
Number of Analysts
8

Next Earnings Revisions

Revenue (1 Month)
-0.66%
Revenue (3 Months)
0.41%
EPS (1 Month)
-35.15%
EPS (3 Months)
11.24%

Next Earnings Summary

SUPN is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is 0.5 USD and the consensus revenue estimate is 196.82M USD.
The next earnings revenue estimate has been revised upward by 0.41% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
SUPN revenue by date.SUPN revenue by date.
607.521M
-8.94%		661.817M
8.94%		718.952M
8.63%		882.31M
22.72%		1.042B
18.10%		1.185B
13.72%		1.335B
12.66%		1.397B
4.64%		1.508B
7.95%		1.598B
5.97%		1.29B
-19.27%
EBITDA
YoY % growth
SUPN ebitda by date.SUPN ebitda by date.
99.779M
-24.18%		170.98M
71.36%		104.105M
-39.11%		158M
51.77%		267.8M
69.49%		378.57M
41.36%		445.74M
17.74%		469.2M
5.26%		482.05M
2.74%		513.06M
6.43%		N/A
EBIT
YoY % growth
SUPN ebit by date.SUPN ebit by date.
14.92M
-67.64%		90.566M
507.01%		12.542M
-86.15%		98.428M
684.79%		240.46M
144.30%		353.53M
47.02%		487.07M
37.77%		514.67M
5.67%		615.77M
19.64%		723.14M
17.44%		586.19M
-18.94%
Operating Margin
SUPN operating margin by date.SUPN operating margin by date.
2.46%13.68%1.74%11.16%23.08%29.83%36.48%36.84%40.83%45.25%45.44%
EPS
YoY % growth
SUPN eps by date.SUPN eps by date.
1.40
35.92%		2.95
110.71%		3.19
8.14%		1.96
-38.50%		4.88
148.79%		5.30
8.53%		7.04
32.96%		7.15
1.52%		8.72
21.97%		10.25
17.54%		8.01
-21.89%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		0.50
14.75%		0.67
-25.48%		1.25
24.22%		1.23
46.93%
Revenue
Q2Q % growth		196.82M
31.37%		215.96M
30.53%		230.6M
20.04%		241.13M
13.97%
EBITDA
Q2Q % growth		13.4M
32.32%		27.045M
-49.81%		80.56M
6.25%		59.364M
-35.18%
EBIT
Q2Q % growth		10.171M
199.17%		23.08M
90.10%		43.679M
370.93%		83.844M
598,785.71%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

SUPN Yearly Revenue VS EstimatesSUPN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B
SUPN Yearly EPS VS EstimatesSUPN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
18.42%
EPS Next 5 Year
17.52%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
18.26%
Revenue Next 5 Year
14.29%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
40.14%
EBIT Next 5 Year
27.81%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

SUPERNUS PHARMACEUTICALS INC / SUPN Forecast FAQ

What do analysts expect the price target to be for SUPERNUS PHARMACEUTICALS INC (SUPN)?

12 analysts have analysed SUPN and the average price target is 62.56 USD. This implies a price increase of 26.78% is expected in the next year compared to the current price of 49.345.

What is the next earnings date for SUPN stock?

SUPERNUS PHARMACEUTICALS INC (SUPN) will report earnings on 2026-05-04.

What are the consensus estimates for SUPN stock next earnings?

The consensus EPS estimate for the next earnings of SUPERNUS PHARMACEUTICALS INC (SUPN) is 0.5 USD and the consensus revenue estimate is 196.82M USD.

How do analysts rate SUPERNUS PHARMACEUTICALS INC (SUPN)?

The consensus rating for SUPERNUS PHARMACEUTICALS INC (SUPN) is 83.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.